Gonzalo Sanchez-Duffhues

BMP signaling in vascular diseases.

Antisense-oligonucleotide mediated exon skipping in activin-receptor-like kinase 2: inhibiting the receptor that is overactive in fibrodysplasia ossificans progressiva.

Clinical Utility Gene Card for: Fibrodysplasia ossificans progressiva.

SLUG is expressed in endothelial cells lacking primary cilia to promote cellular calcification.

Osteochondromas in fibrodysplasia ossificans progressiva: a widespread trait with a streaking but overlooked appearance when arising at femoral bone end.

Bone morphogenetic protein signaling in bone homeostasis.

Bone morphogenetic protein 6 and oxidized low-density lipoprotein synergistically recruit osteogenic differentiation in endothelial cells.

In Brief: Endothelial-to-mesenchymal transition.

Signal Transduction: Gain of Activin Turns Muscle into Bone.

Emerging regulators of BMP bioavailability.

Towards a cure for Fibrodysplasia ossificans progressiva.

Involvement of inflammation and its related microRNAs in hepatocellular carcinoma.

Endothelial-to-mesenchymal transition in cardiovascular diseases: Developmental signaling pathways gone awry.

TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases.

The therapeutic potential of targeting the endothelial-to-mesenchymal transition.

Bone morphogenetic protein receptor signal transduction in human disease.

Inflammation induces endothelial-to-mesenchymal transition and promotes vascular calcification through downregulation of BMPR2.

Endothelial Colony Forming Cells as an Autologous Model to Study Endothelial Dysfunction in Patients with a Bicuspid Aortic Valve.

Generation of Fibrodysplasia ossificans progressiva and control integration free iPSC lines from periodontal ligament fibroblasts.

Development of Macrocycle Kinase Inhibitors for ALK2 Using Fibrodysplasia Ossificans Progressiva-Derived Endothelial Cells.

Mutant ACVR1 Arrests Glial Cell Differentiation to Drive Tumorigenesis in Pediatric Gliomas.

TGF-β-Induced Endothelial to Mesenchymal Transition in Disease and Tissue Engineering.

Bone morphogenetic protein receptors: Structure, function and targeting by selective small molecule kinase inhibitors.

Exacerbated inflammatory signaling underlies aberrant response to BMP9 in pulmonary arterial hypertension lung endothelial cells.